...Northwestern University describes a new therapeutic to deplete GPX4. The researchers designed functional lipoprotein-like nanoparticles (Flip-NPs...
...deplete cholesterol in the cell membrane, leading to a reduction in GPX4 expression and ferroptosis. Flip-NPs...

...indication. Takeda's Shire plc unit gained the analog of GLP-2 through its 2015 acquisition of NPS Pharmaceuticals Inc....

...also venture partner at Blackstone, will join the company's board along with former CEO of NPS Pharmaceuticals Inc....

...has rights outside of China, Japan, North and South Korea and Taiwan to cinacalcet from NPS Pharmaceuticals Inc....
...plc (LSE:SHP; NASDAQ:SHPG) acquired. Kyowa has rights in the Asian countries from a deal with NPS...

...nanoparticles (AC-NPs) could enhance immune responses to radiotherapy plus checkpoint inhibitors to treat cancer. The AC-NPs...
...tumor cells after radiotherapy-induced cell death. In xenograft mouse models of melanoma and breast cancer, AC-NPs...
...survival compared with free tumor antigens plus radiotherapy and the antibody. In the melanoma model, AC-NPs...

...has rights outside of China, Japan, North and South Korea and Taiwan to cinacalcet from NPS Pharmaceuticals Inc....
...plc (LSE:SHP; NASDAQ:SHPG) acquired. Kyowa has rights in the Asian countries from a deal with NPS...

...related to several other receptors, including orexin ( hypocretin ; HCRT ) and neuropeptide S (NPS...

...patents covering Gattex. The last expires in 2025. Shire gained Gattex through its acquisition of NPS Pharmaceuticals Inc....

...Drug delivery TECHNOLOGY: Nanoparticles RNA transcripts nanoparticles (RNAtr NPs) could be used to deliver siRNA to...
...testing RNAtr NP-based delivery of therapeutic siRNAs in tumor models. DESCRIPTION: RNA transcripts nanoparticles (RNAtr NPs...

...IPR petition filed by Bass' Coalition for Affordable Drugs LLC against a patent held by NPS...
...on several questions related to the legality of IPR challenges like those Bass has filed. NPS...
...intended solely to create short-term trading opportunities and should be prohibited. In addition to the NPS...